Skip to content
★ Sign in to follow
CD

Chetan Doshi

Executive
Eris Lifesciences Limited
Total declarations
11
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€74k

Latest filing published 21 Jun 2022 for Eris Lifesciences Limited, €27k.

Filing timeline

BuySale
Chetan Doshi

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

Closed purchases

Market purchases
5

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Chetan Doshi: trading record in brief

Chetan Doshi, listed as chief executive, appears in our data through filings on Eris Lifesciences Limited shares, published by SEBI (PIT + SAST). We count 11 filings; the first trade dates from 13 July 2021 and the latest from 21 June 2022.

The open-market record consists of 6 sales worth €74k, with no purchase. Outside the open market, there are 5 share grants. 2022 to date brings no purchases and 1 sale.

The latest filing, published on 21 June 2022, reports a share grant of €27k in Eris Lifesciences Limited. Most trades are made public on the day they happen. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Chetan Doshi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total
  • ▲
    ExecutivesEris Lifesciences Limited
    2M INR15SEBI
    4,943 shares@ ₹451.039914.8% of flowEquity SharesSEBI:e2dedc089554609110ce2149c7ec29b9795e0a96
    Canonical exit: 19 Sept 2022 (T+90)
  • ▼
    ExecutivesEris Lifesciences Limited
    1M INR15SEBI
    2,000 shares@ ₹708.909.5% of flowEquity SharesSEBI:551ee794d154ecf34fb3155433e3e2a78426d18d
  • ▲
    ExecutivesEris Lifesciences Limited
    2M INR3SEBI
    4,500 shares@ ₹451.0413.4% of flowEquity SharesSEBI:6e631b975ce6fa84b665fb8dca21faa71afdd9ba
    Canonical exit: 13 Jul 2022 (T+90)
  • ▲
    ExecutivesEris Lifesciences Limited
    4M INR16SEBI
    8,000 shares@ ₹451.0423.0% of flowEquity SharesSEBI:281483c3b96cc0b744dadb278cf0c85b34dcafb8
    Canonical exit: 21 Mar 2022 (T+90)
  • ▼
    ExecutivesEris Lifesciences Limited
    798,950 INR15SEBI
    1,000 shares@ ₹798.955.2% of flowEquity SharesSEBI:9af7b2af1ff0271615b0b648ed6af8481633e752
  • ▲
    ExecutivesEris Lifesciences Limited
    1M INR18SEBI
    2,500 shares@ ₹451.047.1% of flowEquity SharesSEBI:dbe95b9dd9ff1c0e43a92abe82860d4de8a8c57c
    Canonical exit: 23 Dec 2021 (T+90)
  • ▼
    ExecutivesEris Lifesciences Limited
    678,258 INR23SEBI
    882 shares@ ₹769.0034.1% of flowEquity SharesSEBI:d3725ff77af1ed1de9c51c88bfe166876fcd7152
  • ▼
    ExecutivesEris Lifesciences Limited
    1M INR27SEBI
    1,750 shares@ ₹748.71310.0009% mcap65.9% of flowEquity SharesSEBI:82a0a4fed8e840497616366981b0d87b4bccceff
  • ▼
    ExecutivesEris Lifesciences Limited
    942,312 INR15SEBI
    1,250 shares@ ₹753.84960.0006% mcap5.9% of flowEquity SharesSEBI:d93db563d9a6ce77d4a2dc433566c6a8eb88470a
  • ▼
    1M INR15SEBI
    1,500 shares@ ₹768.40870.0008% mcap7.1% of flowEquity SharesSEBI:3f00d320bda82b2addff28ff83eb25da21d66877
  • ▲
    ExecutivesEris Lifesciences Limited
    2M INR21SEBI
    5,000 shares@ ₹451.0414.0% of flowEquity SharesSEBI:b26f4408e82b4d3216e337fe771ca0722e8670b9
    Canonical exit: 11 Oct 2021 (T+90)

11 of 11 declarations